Aeglea BioTherapeutics, Inc. AGLE

Set alert

Price alert · AGLE

All alert types
12.01 +12.01 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
48.63M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-6.53
Beta
2.57
Short ratio
3.68
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2023
50-d avg
12.64
200-d avg
9.84
1y target
17.50

3M chart

Chart tools
Interval

Events in this range
  • Nov 9, 2023Earnings: —; estimate -0.44; surprise —%
Signals (19)
NameDateAgo
MACD: Sell SignalDec 14, 20232 years ago
RSI: OverboughtNov 29, 20232 years ago
SMA: BullishNov 27, 20232 years ago
SMA: BullishNov 27, 20232 years ago
MACD: Buy SignalNov 20, 20232 years ago
MACD: Sell SignalOct 25, 20233 years ago
SMA: BearishOct 24, 20233 years ago
SMA: BearishOct 23, 20233 years ago
SMA: BullishOct 20, 20233 years ago
SMA: BullishOct 20, 20233 years ago
SMA: BearishOct 19, 20233 years ago
SMA: BearishOct 19, 20233 years ago
SMA: BullishOct 13, 20233 years ago
SMA: BullishOct 13, 20233 years ago
SMA: BearishOct 11, 20233 years ago
SMA: BearishOct 11, 20233 years ago
SMA: BullishOct 10, 20233 years ago
SMA: BullishOct 10, 20233 years ago
MACD: Buy SignalOct 9, 20233 years ago

Analyst view

Consensus: buy

Buy
Price target (mean) 17.50 +45.7% upside
Target (low)
12.00
Target (mean)
17.50
Target (high)
23.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 2
  • 2 months ago 2
  • 3 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

AGLE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.91-1.15 – -0.67-4.50+79.8%00.0%2
Next quarter-0.58-0.58 – -0.58-5.00+88.4%00.0%1
Current year-5.33-5.57 – -5.09-24.75+78.5%900.00K-61.4%2
Next year-1.84-2.16 – -1.53-5.33+65.5%20.00M+2122.2%2